Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03448380 · ClinicalTrials.gov registry record
FreeStyle Libre Flash Glucose Monitoring System Post Approval Study
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 935
- Enrollment target
NCT03448380 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 935 participants.
The verdict
NCT03448380 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 935 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, non-randomized, single-arm, post-approval study of the FreeStyle Libre Flash Glucose Monitoring System intended to characterize the safety of the Libre Flash Glucose Monitoring System when used in people with diabetes.
Interventions
- DEVICE FreeStyle Libre Flash Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 935 participants |
| Start Date | 2018-02-27 |
| Est. Completion | 2021-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03448380
The ClinicalTrials.gov registry entry for NCT03448380 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 935 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Libre Flash Glucose Monitoring System is the first listed.
NCT03448380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03448380 about?
NCT03448380 is a clinical study titled "FreeStyle Libre Flash Glucose Monitoring System Post Approval Study". This is a prospective, multi-center, non-randomized, single-arm, post-approval study of the FreeStyle Libre Flash Glucose Monitoring System intended to characterize the safety of the Libre Flash Glucose Monitoring System when used in people with diabetes.
What is the current status of trial NCT03448380?
This trial is currently completed. The enrollment target is 935 participants. The study started on 2018-02-27. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT03448380?
The interventions under investigation include: FreeStyle Libre Flash Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT03448380?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.